The Cancer Genome Characterization Center (CGCC) at the Broad Institute of MIT and Harvard brings together a team of investigators with extensive expertise in cancer and genomics, as well as a track record of setting and attaining milestones. As part of The Cancer Genome Atlas (TCGA) pilot project, we propose to accomplish the following objectives: (1) Characterize structural alterations (amplification, deletion and LOH) and gene expression in a large collection of cancer samples. Specifically, we will use microarrays to perform high-density SNP genotyping and RNA expression profiling. We will analyze 1000, 1500 and 2000 samples in years 1, 2 and 3, respectively - with costs decreasing to allow an increasing number of samples on a roughly constant budget. (2) Improve the cost and performance of SNP genotyping and RNA expression profiling, by designing new, more efficient arrays. In particular, we will decrease total costs by a factor of at least 2-fold for the same information content. By the end of the project, it will be possible to characterize genome alteration and gene expression in a collection of 15,000 cancer samples (the target suggested in NCI's report on TCGA) at a total cost of <$6M/year over a three-year period. These technologies will thus be ready for full scale up within TCGA. (3) Cross-validate, integrate, and analyze CGCC data to determine regions of genome alteration for high-throughput sequencing. (4) Rapidly share data with the cancer research community. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Resource-Related Research Projects--Cooperative Agreements (U24)
Project #
5U24CA126546-02
Application #
7294309
Study Section
Special Emphasis Panel (ZCA1-SRRB-U (O1))
Program Officer
Lee, Jerry S
Project Start
2006-09-28
Project End
2009-08-31
Budget Start
2007-09-15
Budget End
2008-08-31
Support Year
2
Fiscal Year
2007
Total Cost
$2,363,991
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
Organized Research Units
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Imielinski, Marcin; Guo, Guangwu; Meyerson, Matthew (2017) Insertions and Deletions Target Lineage-Defining Genes in Human Cancers. Cell 168:460-472.e14
Campbell, Joshua D; Alexandrov, Anton; Kim, Jaegil et al. (2016) Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet 48:607-16
Ceccarelli, Michele; Barthel, Floris P; Malta, Tathiane M et al. (2016) Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell 164:550-63
Cancer Genome Atlas Research Network (see original citation for additional authors) (2015) Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 372:2481-98
Helman, Elena; Lawrence, Michael S; Stewart, Chip et al. (2014) Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing. Genome Res 24:1053-63
Cancer Genome Atlas Research Network (2014) Comprehensive molecular profiling of lung adenocarcinoma. Nature 511:543-50
Van Allen, Eliezer M; Wagle, Nikhil; Stojanov, Petar et al. (2014) Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat Med 20:682-8
Watanabe, Hideo; Ma, Qiuping; Peng, Shouyong et al. (2014) SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas. J Clin Invest 124:1636-45
Brennan, Cameron W; Verhaak, Roel G W; McKenna, Aaron et al. (2013) The somatic genomic landscape of glioblastoma. Cell 155:462-77
Carter, Scott L; Cibulskis, Kristian; Helman, Elena et al. (2012) Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 30:413-21

Showing the most recent 10 out of 20 publications